DNER and acute lymphoblastic leukemia: It has been applied alone or in combination with other BET inhibitors, for instance, GSK343 and OTX015, to suppress the proliferation of T cell acute lymphoblastic leukemia (T-ALL) cells, and promote their apoptosis.